Page last updated: 2024-11-05

thiotepa and Granulomatosis, Lymphomatoid

thiotepa has been researched along with Granulomatosis, Lymphomatoid in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research Excerpts

ExcerptRelevanceReference
"Primary lymphomatoid granulomatosis of the CNS (CNS-LG) is a rare lymphoid neoplasia associated Epstein-Barr Virus (EBV) and often accompanied by immunodeficiencies."1.91High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system. ( Nilius-Eliliwi, V; Schroers, R; Seidel, S; Treiber, H; Vangala, DB, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nilius-Eliliwi, V1
Treiber, H1
Seidel, S1
Vangala, DB1
Schroers, R1

Other Studies

1 other study available for thiotepa and Granulomatosis, Lymphomatoid

ArticleYear
High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:9

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Ne

2023